TY  - JOUR 
AU  - Tschöp, M.
AU  - Nogueiras Pozo, Rubén
AU  - Ahrén, B.
PY  - 2023
SN  - 1432-0428
UR  - http://hdl.handle.net/20.500.11940/21546
AB  - Glucagon-like peptide-1 (GLP-1) receptor agonists are established pharmaceutical therapies for the treatment of type 2 diabetes and obesity. They mimic the action of GLP-1 to reduce glucose levels through stimulation of insulin secretion and...
LA  - eng
KW  - Humans
KW  - Glucagon
KW  - Diabetes Mellitus, Type 2
KW  - Glucagon-Like Peptide 1
KW  - Body Weight
KW  - Obesity
KW  - Glucose
KW  - Glucagon-Like Peptide-1 Receptor Agonists
TI  - Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy
DO  - 10.1007/s00125-023-05929-0
T2  - Diabetologia
M2  - 1796
VL  - 66
ER  -